about
Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challengesAcute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphomaIdentification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease.Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosisAutomated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence testsSimultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.A highly versatile microscope imaging technology platform for the multiplex real-time detection of biomolecules and autoimmune antibodies.Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.DNA double-strand breaks and micronuclei in human blood lymphocytes after repeated whole body exposures to 7T Magnetic Resonance Imaging.Porcine E. coli: virulence-associated genes, resistance genes and adhesion and probiotic activity tested by a new screening method.Glycoprotein 2 antibodies in Crohn's disease.Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease.Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human LymphocytesAnalysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.New platform technology for comprehensive serological diagnostics of autoimmune diseasesSimultaneous detection of celiac disease-specific IgA antibodies and total IgA.The Novel Crohn's Disease Marker Anti-GP2 Antibody Is Associated with Ileocolonic Location of Disease.Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis.Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.Adhesion of human and animal Escherichia coli strains in association with their virulence-associated genes and phylogenetic origins.Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.Stable expression of human muscle-specific kinase in HEp-2 M4 cells for automatic immunofluorescence diagnostics of myasthenia gravis.Profiling of rheumatoid arthritis associated autoantibodies.Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies.Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found.Diagnosis and classification of Crohn's disease.Diagnosis and classification of ulcerative colitis.Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.Autoimmunity in Crohn's Disease-A Putative Stratification Factor of the Clinical Phenotype.Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.Adhesion patterns of commensal and pathogenic Escherichia coli from humans and wild animals on human and porcine epithelial cell lines.Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses.Fully automated interpretation of ionizing radiation-induced γH2AX foci by the novel pattern recognition system AKLIDES®.Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.Impact of in Vivo High-Field-Strength and Ultra-High-Field-Strength MR Imaging on DNA Double-Strand-Break Formation in Human Lymphocytes.Simultaneous comprehensive multiplex autoantibody analysis for rapidly progressive glomerulonephritisExpression of nicotinic acetylcholine receptor subunits in HEp-2 cells for immunodetection of autoantibody specificities in sera from Myasthenia gravis patients.Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
P50
Q26823779-F80B2BDB-9B8B-4D4B-8024-8844F22E4855Q33405441-8861C118-36A2-48BA-81FE-944BC3A65FF8Q33473077-5055EA2A-38A7-4B82-A56B-CE9F4FC40D2FQ33629819-30B5698C-1C39-4E1E-A913-E3209A17E40DQ33634999-6D469237-BE39-4308-A0E6-228FF23CCF89Q33923278-8A3AC7E0-B64D-475D-8579-D5A2A56B2725Q34199391-1F7A95D4-C5B9-455A-899E-4EBA17EF2192Q34205446-D5D6DBC5-3ED3-4C54-9505-F8A1247258D8Q34367414-FCC930BC-D841-4A91-BB43-5A9BC4471BC6Q34519000-0FACCE66-8661-40FF-8F8B-673F9B83C135Q34711939-B24CEFAC-6EC1-4BD0-91A3-231C1EF2FE6EQ34750329-9A126ACB-DA84-4333-8196-61DD01B67F05Q35654500-F5C7C9CD-79D8-4E18-BA3D-CF39473E3478Q35691970-AFF32467-2DBE-4DB1-9E63-0D8C7942ACBCQ35907244-1FA8A0C1-A74C-4FE5-BC97-5A5775205C75Q36355419-810E91BF-84DC-4F97-8E84-6DFEF2BE3FDDQ36505735-0922EFB1-2A23-4E50-AC71-4E5A6FEA9400Q36523415-D4E632E0-EA29-4FBD-95DB-7AE4C821B69AQ36898669-DD7F3F84-3811-42C7-8D7A-C1C0C81841E6Q36907743-6FAB5F73-DB54-4F37-AA78-4BD87228689EQ36923241-31100CD3-F33F-4069-AA68-E0CA0FA000F2Q37263655-9FFE9446-5C08-414E-9F6E-E7DD0F201DA8Q37401978-9D411BC2-FC75-455D-B910-A927C1113C21Q37458471-612331C5-46F0-4164-B5A2-D2D11FDE288AQ37637006-66B69240-A0AC-410D-AED3-EAF8709912AAQ37943676-26F5115F-C8A0-4B26-B78D-F237C590DBABQ38008773-7D34FEE2-6B33-4E01-8738-B154F62383E8Q38178476-55EFB700-7D5C-4AD3-8923-25286732D57CQ38178485-6B9B0FE4-EB1B-4527-8BCB-28CF2DAF182BQ38497438-6576A680-5CB4-44D0-898D-B2427DE557FDQ38813594-6D6AF246-5B36-453B-85DA-6CFC873C47C9Q38883608-9BE152B6-D716-4D41-87FF-F57FB2B2BEA9Q39067363-C18B89BF-C172-4024-BF83-92CB8D1F4E13Q39297770-69161C26-5B02-4EFC-A12A-195B6801F14DQ39405811-8EB3D956-CDC5-44E9-8D35-D6B8AB564C76Q39613357-C620F7F8-E723-4218-B2FB-317A6834B66BQ40409366-079513CD-3CD0-49C7-B4F2-79D1A85BC80CQ40446804-1CB2B1F4-91E7-4D53-9E7B-9499FB1648FBQ40495661-F5F53B5C-B89D-46C1-93F8-D96BDCFE6F20Q40578397-E9AD9489-12D6-4F0B-B73D-7A585E7589CD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dirk Roggenbuck
@ast
Dirk Roggenbuck
@en
Dirk Roggenbuck
@es
Dirk Roggenbuck
@nl
Dirk Roggenbuck
@sl
type
label
Dirk Roggenbuck
@ast
Dirk Roggenbuck
@en
Dirk Roggenbuck
@es
Dirk Roggenbuck
@nl
Dirk Roggenbuck
@sl
prefLabel
Dirk Roggenbuck
@ast
Dirk Roggenbuck
@en
Dirk Roggenbuck
@es
Dirk Roggenbuck
@nl
Dirk Roggenbuck
@sl
P106
P1153
6602574293
P21
P31
P496
0000-0002-6861-6827